Association between single nucleotide polymorphisms (SNPs) of XRCC2 and XRCC3 homologous recombination repair genes and triple-negative breast cancer in Polish women
- PMID: 24728564
- PMCID: PMC4544483
- DOI: 10.1007/s10238-014-0284-7
Association between single nucleotide polymorphisms (SNPs) of XRCC2 and XRCC3 homologous recombination repair genes and triple-negative breast cancer in Polish women
Abstract
XRCC2 and XRCC3 genes involved in homologous recombination repair (HRR) of DNA and in the maintenance of the genome integrity play a crucial role in protecting against mutations that lead to cancer. The aim of the present work was to evaluate associations between the risk of triple-negative breast cancer (TNBC) and polymorphisms in the genes, encoding for two key proteins of HRR: XRCC2 Arg188His (c. 563 G>A; rs3218536, Genbank Accession Number NT 007914) and XRCC3 Thr241Met (c. 722 C>T; rs861539, Genbank Accession Number NT 026437). The polymorphisms of the XRCC2 and XRCC3 were investigated by PCR-RFLP in 70 patients with TNBC and 70 age- and sex-matched non-cancer controls. In the present work, a relationship was identified between XRCC2 Arg188His polymorphism and the incidence of triple-negative breast cancer. The 188His allele and 188His/His homozygous variant increased cancer risk. An association was confirmed between XRCC2 Arg188His and XRCC3 Thr241Met polymorphisms and TNBC progression, assessed by the degree of lymph node metastases and histological grades. In conclusion, XRCC2 Arg188His and XRCC3 Thr241Met polymorphisms may be regarded as predictive factors of triple-negative breast cancer in female population.
Similar articles
-
Association between single nucleotide polymorphisms (SNPs) of XRCC2 and XRCC3 homologous recombination repair genes and ovarian cancer in Polish women.Exp Mol Pathol. 2016 Apr;100(2):243-7. doi: 10.1016/j.yexmp.2016.01.007. Epub 2016 Jan 19. Exp Mol Pathol. 2016. PMID: 26801223
-
Single nucleotide polymorphisms in the homologous recombination repair genes and breast cancer risk in Polish women.Tohoku J Exp Med. 2011 Jul;224(3):201-8. doi: 10.1620/tjem.224.201. Tohoku J Exp Med. 2011. PMID: 21701125
-
Single Nucleotide Polymorphisms (SNPs) of RAD51-G172T and XRCC2-41657C/T Homologous Recombination Repair Genes and the Risk of Triple- Negative Breast Cancer in Polish Women.Pathol Oncol Res. 2015 Sep;21(4):935-40. doi: 10.1007/s12253-015-9922-y. Epub 2015 Mar 7. Pathol Oncol Res. 2015. PMID: 25743260 Free PMC article.
-
Association between XRCC2 Arg188His Polymorphism and Breast Cancer Susceptibility: A Systematic Review and Meta-Analysis.Asian Pac J Cancer Prev. 2024 Jan 1;25(1):43-55. doi: 10.31557/APJCP.2024.25.1.43. Asian Pac J Cancer Prev. 2024. PMID: 38285766 Free PMC article.
-
XRCC3 Thr241Met polymorphism and gastric cancer susceptibility: a meta-analysis.Clin Res Hepatol Gastroenterol. 2014 Apr;38(2):226-34. doi: 10.1016/j.clinre.2013.10.011. Epub 2013 Dec 4. Clin Res Hepatol Gastroenterol. 2014. PMID: 24315014 Review.
Cited by
-
Association of XRCC2 rs3218536 Polymorphism with Susceptibility of Breast and Ovarian Cancer: A Systematic Review and Meta-Analysis.Asian Pac J Cancer Prev. 2017 Jul 27;18(7):1743-1749. doi: 10.22034/APJCP.2017.18.7.1743. Asian Pac J Cancer Prev. 2017. PMID: 28749098 Free PMC article.
-
Association of Polymorphisms in DNA Repair Gene XRCC3 with Asthma in Taiwan.In Vivo. 2018 Sep-Oct;32(5):1039-1043. doi: 10.21873/invivo.11344. In Vivo. 2018. PMID: 30150425 Free PMC article.
-
Relationship between polymorphisms in homologous recombination repair genes RAD51 G172T、XRCC2 & XRCC3 and risk of breast cancer: A meta-analysis.Front Oncol. 2023 Jan 24;13:1047336. doi: 10.3389/fonc.2023.1047336. eCollection 2023. Front Oncol. 2023. PMID: 36761956 Free PMC article.
-
Polymorphism of DNA Repair Genes via Homologous Recombination (HR) in Ovarian Cancer.Pathol Oncol Res. 2019 Oct;25(4):1607-1614. doi: 10.1007/s12253-019-00604-5. Epub 2019 Feb 2. Pathol Oncol Res. 2019. PMID: 30712190 Free PMC article.
-
An association between the -41657 C/T polymorphism of X-ray repair cross-complementing 2 (XRCC2) gene and ovarian cancer.Med Oncol. 2014 Dec;31(12):300. doi: 10.1007/s12032-014-0300-5. Epub 2014 Oct 30. Med Oncol. 2014. PMID: 25355640 Clinical Trial.
References
-
- Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the socalled triple-negative phenotype: a population-based study from the California cancer registry. Cancer. 2007;109:1721–1728. doi: 10.1002/cncr.22618. - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials